Replies to post #1522 on Conatus Pharmaceuticals Inc. (CNAT)

[Inoviorulez]

Thanks for the poster, good information Emricasan is blockbuster potential. All those selling now will regret it IMO

[Theo]

From StockNews.com CNAT – Granted orphan designation by the FDA for its compound for the treatment of primary sclerosing cholangitis.

Full disclosure, I can't find it on the FDA website (yet anyway) or the company's website.

???